| Item Type | Name |
|
Concept
|
Small Cell Lung Carcinoma
|
|
Academic Article
|
Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases.
|
|
Academic Article
|
Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non?small-cell lung cancer or lung metastases.
|
|
Academic Article
|
C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expression.
|
|
Academic Article
|
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
|
|
Academic Article
|
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.
|
|
Academic Article
|
Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.
|
|
Academic Article
|
Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes.
|
|
Academic Article
|
Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy.
|
|
Academic Article
|
Stereotactic body radiation therapy in non-small-cell lung cancer: linking radiobiological modeling and clinical outcome.
|
|
Academic Article
|
Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy.
|
|
Academic Article
|
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
|
|
Academic Article
|
What would be the most appropriate a/? ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer.
|
|
Academic Article
|
Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.
|
|
Academic Article
|
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.
|
|
Academic Article
|
Progress in the management of limited-stage small cell lung cancer.
|
|
Academic Article
|
Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond.
|
|
Academic Article
|
Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.
|
|
Academic Article
|
Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.
|
|
Academic Article
|
Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation.
|
|
Academic Article
|
Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.
|
|
Academic Article
|
Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Single Nucleotide Polymorphisms in CBLB, a?Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.
|
|
Academic Article
|
Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer
|
|
Academic Article
|
Intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy strategies for locally advanced non-small-cell lung cancer
|
|
Academic Article
|
Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer
|
|
Academic Article
|
Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
|
|
Academic Article
|
Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer.
|
|
Academic Article
|
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.
|
|
Academic Article
|
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
|
|
Academic Article
|
Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival.
|
|
Academic Article
|
Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.
|
|
Academic Article
|
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.
|
|
Academic Article
|
Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy.
|
|
Academic Article
|
Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II Trials.
|
|
Academic Article
|
Hematologic variables associated with brain failure in patients with small-cell lung cancer.
|
|
Academic Article
|
Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
|
|
Academic Article
|
Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis.
|
|
Academic Article
|
Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer.
|
|
Academic Article
|
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.
|
|
Academic Article
|
Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.
|
|
Academic Article
|
Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
|
|
Academic Article
|
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.
|
|
Academic Article
|
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials.
|
|
Academic Article
|
Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer.
|
|
Academic Article
|
SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes.
|
|
Academic Article
|
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC.
|
|
Academic Article
|
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.
|
|
Academic Article
|
The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
|
|
Academic Article
|
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.
|
|
Academic Article
|
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study.
|
|
Academic Article
|
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
|
|
Academic Article
|
Combined treatment of non-small cell lung cancer using radiotherapy and immunotherapy: challenges and updates.
|
|
Academic Article
|
T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.
|
|
Academic Article
|
Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer.
|
|
Academic Article
|
Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial.
|
|
Academic Article
|
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
|
|
Academic Article
|
Bombarding Oligoprogression: Oncologic Outcomes After Radiation to Patients With Oligoprogressive Non-Small Cell Lung Cancer on Maintenance Systemic Therapy.
|
|
Academic Article
|
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma.
|